LONDON, UK: DNA Electronics Ltd., an innovator of semiconductor solutions for healthcare, has signed a non-exclusive, worldwide license agreement to provide Ion Torrent, the semiconductor sequencing company, access to DNA Electronics’ intellectual property. No further details about the agreement were disclosed.
DNA Electronics Founder and CEO Prof. Chris Toumazou FRS, an electronic engineer and innovator who has spent his career working in semiconductor technology, moved into healthcare because he saw the huge benefits chip technology could offer clinicians.
“I’ve always believed that if you could apply just a fraction of semiconductor technology to healthcare, you can begin to make major innovations,” said Toumazou.
“Those innovations are now very near on the horizon, and the great work that DNA Electronics has been doing positions our company to play a key role in this coming healthcare revolution. I am delighted that Ion Torrent is pioneering semiconductor sequencing, and I believe this will bring about a new semiconductor revolution in the Life Sciences and Healthcare industries.”